期刊
ANNALS OF DERMATOLOGY
卷 22, 期 3, 页码 245-254出版社
KOREAN DERMATOLOGICAL ASSOC
DOI: 10.5021/ad.2010.22.3.245
关键词
Antimicrobial peptides; Atopic dermatitis; Barrier function; Barrier repair
类别
资金
- NIH [R01-AR019098, R01-AI059311]
- DOD [W81XWH-05-2-0094]
- Medical Research Service, Department of Veterans Affairs
In this review, I first provide relevant background information about normal epidermal barrier structure and function. I then update recent information about how inherited defects in either filaggrin and/or in the serine protease inhibitor, lymphoepithelial Kazal-type inhibitor 1, converge to stimulate the development of atopic dermatitis (AD). Next I explain the multiple mechanisms whereby a primary barrier abnormality in AD can lead to inflammation. Furthermore, I explore how certain acquired stressors, such as a reduced external humidity, high pH soaps/surfactants, psychological stress, as well as secondary Staphylococcus aureus infections initiate or further aggravate AD. Finally, and most importantly, I compare various therapeutic paradigms for AD, highlighting the risks and benefits of glucocorticoids and immunomodulators vs. corrective, lipid replacement therapy. (Ann Dermatol 22(3) 245 similar to 254, 2010)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据